Table 2 The relationship between clinicopathological characteristics and survival in patients undergoing potentially curative resection for colorectal cancer
All patients ( n =206) | Node negative ( n =117) | |||||
|---|---|---|---|---|---|---|
Cancer-specific survival | Cancer-specific survival | |||||
Univariate analysis | Univariate analysis | |||||
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (<65/65–74/>75) | 0.79 | 0.49–1.27 | 0.330 | 0.10 | 0.24–1.14 | 0.101 |
Gender (male/female) | 1.24 | 0.58–2.63 | 0.570 | 4.23 | 0.92–19.41 | 0.064 |
Site (colon/rectum) | 1.03 | 0.49–2.19 | 0.930 | 1.55 | 0.49–4.80 | 0.450 |
T-stage (T1/T2/T3/T4) | 2.75 | 0.49–5.07 | 0.001 | 1.69 | 0.77–3.70 | 0.190 |
TNM stage I/II/III/IV | 2.31 | 1.28–4.17 | 0.005 | 4.13 | 0.53–32.08 | 0.180 |
Pre-operative mGPS (0/1/2) | 1.94 | 1.17–3.21 | 0.010 | 2.57 | 1.10–5.96 | 0.028 |
Pre-operative NLR (<5/>5) | 3.28 | 1.36–7.93 | 0.008 | 2.08 | 0.62–2.09 | 0.233 |
Post-operative mGPS (0/1/2) | 3.31 | 2.15–5.09 | <0.001 | 4.81 | 2.13–10.83 | <0.001 |
Post-operative NLR (<5/>5) | 3.07 | 1.42–6.62 | 0.004 | 3.10 | 0.98–9.84 | 0.054 |
